【ChiCTR2600118687】Effects of nature-based mindfulness training on depression among adults with childhood adversity: A randomised controlled trial
ChiCTR2600118687
尚未开始
/
/
/
2026-02-10
/
/
Depression awith childhood adversity
Effects of nature-based mindfulness training on depression among adults with childhood adversity: A randomised controlled trial
Effects of nature-based mindfulness training on depression among adults with childhood adversity: A randomised controlled trial
Objectives: 1. PInvestigate the effect of Nature-based Mindfulness Training (NBMT) on reducing depressive symptoms among adults with depression and adverse childhood experiences (ACE). 2.Investigate the effect of NBMT on reducing anxiety symptoms and improving quality of life among adults with depression and ACE. 3.Compare the effects of NBMT with MBCT in reducing depressive and anxiety symptoms and improving quality of life . 4.Examine adherence and rumination as potential mediators responsible for better outcomes in NBMT.
随机平行对照
其它
The method of sampling will be stratified randomisation based on sex and psychiatric medication use to achieve demographic balance between the two arms. An experienced independent statistician will generate the randomisation sequence using computer-generated random results.
The research staff member who conducts the assessments or statistical analyses will be blinded to the group assignments.
General Research Fund
/
128
/
2026-02-16
2028-02-16
/
1) Aged 18 years or above 2) Screened by the Patient Health Questionnaire depression scale (PHQ-9) with at least moderate depressive symptoms (i.e. a PHQ score of 10 or above) 3) ACE histories will be collected using the Adverse Childhood Experiences—International Questionnaire (ACE-IQ) with at least one ACE;
请登录查看1) The presence of serious suicidal risk 2) Severe medical illness with a prognosis of less than 6 months to live 3) A diagnosis of antisocial, schizotypal, or borderline personality disorder; 4) A history of schizophrenia, schizoaffective disorder, bipolar disorder, substance abuse, or organic brain disorders.;
请登录查看香港中文大學賽馬會公共衛生及基層醫療學院
/
香港中文大學賽馬會公共衛生及基層醫療學院的其他临床试验
香港中文大學賽馬會公共衛生及基層醫療學院的其他临床试验
最新临床资讯
-
落地临床、抢滩院外,AI康复机器人下一步竞争拼什么?
动脉网-最新2026-08-29
-
再获国际权威学术认可!恒瑞创新药HRS-7535糖尿病肾病Ⅱ期临床研究发表于《柳叶刀》子刊
恒瑞医药2026-08-28
-
贵州百灵2026-08-28
-
癌度2026-08-28
-
UmabsDB2026-08-28
-
扬子江药业集团2026-08-28
-
医药观澜2026-08-28
-
金斯瑞生物2026-08-28
-
科凝生物 Pleryon2026-08-28
-
海创药业2026-08-28
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-30
-
2026-08-30
-
2026-08-30
-
摩熵咨询 20 8
-
摩熵咨询 34 36
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-31
-
2026-08-30
-
2026-08-29
-
摩熵咨询 35 45
-
摩熵咨询 28 45
-
摩熵咨询 34 23
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29

